• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
De novo daptomycin nonsusceptibility in a clinical isolate.临床分离株中达托霉素的从头非敏感性
J Clin Microbiol. 2006 Feb;44(2):673. doi: 10.1128/JCM.44.2.673.2006.
2
Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.在达托霉素治疗期间粪肠球菌中出现达托霉素耐药性。
Antimicrob Agents Chemother. 2005 Apr;49(4):1664-5. doi: 10.1128/AAC.49.4.1664-1665.2005.
3
Mechanisms of resistance to daptomycin in Enterococcus faecium.粪肠球菌对达托霉素的耐药机制
Antimicrob Agents Chemother. 2008 Mar;52(3):1167-70. doi: 10.1128/AAC.00774-07. Epub 2008 Jan 7.
4
In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.达托霉素对金黄色葡萄球菌和肠球菌分离株的体外活性：来自土耳其的初步结果。
Int J Antimicrob Agents. 2004 Jun;23(6):642-3. doi: 10.1016/j.ijantimicag.2004.03.010.
5
Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.一名未曾接触过达托霉素的患者体内出现对达托霉素耐药的屎肠球菌。
J Hosp Infect. 2007 Apr;65(4):376-8. doi: 10.1016/j.jhin.2007.01.002. Epub 2007 Feb 20.
6
In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.替加环素、达托霉素、利奈唑胺和奎奴普丁/达福普汀对耐糖肽粪肠球菌的体外活性。
Int J Antimicrob Agents. 2007 Mar;29(3):358-60. doi: 10.1016/j.ijantimicag.2006.10.007. Epub 2007 Jan 16.
7
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.血液系统恶性肿瘤和造血干细胞移植患者中对达托霉素不敏感的肠球菌：一种新出现的威胁。
Ann Hematol. 2013 Jan;92(1):129-31. doi: 10.1007/s00277-012-1539-6. Epub 2012 Aug 7.
8
Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.成人耐万古霉素屎肠球菌脑膜炎：病例系列及文献综述
Scand J Infect Dis. 2013 Feb;45(2):131-9. doi: 10.3109/00365548.2012.717711. Epub 2012 Sep 19.
9
Susceptibility of enterococci to daptomycin is dependent upon testing methodology.肠球菌对达托霉素的敏感性取决于检测方法。
Diagn Microbiol Infect Dis. 2013 Aug;76(4):497-501. doi: 10.1016/j.diagmicrobio.2013.04.019. Epub 2013 May 27.
10
De novo daptomycin-nonsusceptible enterococcal infections.新生霉素不敏感肠球菌感染。
Emerg Infect Dis. 2012 Apr;18(4):674-6. doi: 10.3201/eid1804.110932.

引用本文的文献

1
Pathogenicity of Enterococci.肠球菌的致病性。
Microbiol Spectr. 2019 Jul;7(4). doi: 10.1128/microbiolspec.GPP3-0053-2018.
2
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?达托霉素治疗粪肠球菌菌血症临床结局中最低抑菌浓度的影响：是时候改变折点了吗？
Clin Infect Dis. 2016 Jun 15;62(12):1514-1520. doi: 10.1093/cid/ciw173. Epub 2016 Apr 3.
3
Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background.liaR基因缺失可逆转屎肠球菌对达托霉素的耐药性，且与遗传背景无关。
Antimicrob Agents Chemother. 2015 Dec;59(12):7327-34. doi: 10.1128/AAC.01073-15. Epub 2015 Sep 14.
4
Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.在屎肠球菌临床分离株中鉴定出一种新型克隆株ST736及其与达托霉素不敏感性的关联。
Antimicrob Agents Chemother. 2014 Aug;58(8):4848-54. doi: 10.1128/AAC.02683-14. Epub 2014 Jun 9.
5
Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.万古霉素敏感屎肠球菌株及其治疗中出现的万古霉素耐药变异株的全基因组分析。
Antimicrob Agents Chemother. 2013 Jan;57(1):261-8. doi: 10.1128/AAC.01454-12. Epub 2012 Oct 31.
6
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.达托霉素暴露先于达托霉素不敏感肠球菌感染和/或定植。
Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19.
7
Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.粪肠球菌 liaFSR 突变与达托霉素 MIC 的相关性：重新探讨达托霉素折点。
Antimicrob Agents Chemother. 2012 Aug;56(8):4354-9. doi: 10.1128/AAC.00509-12. Epub 2012 Jun 4.
8
De novo daptomycin-nonsusceptible enterococcal infections.新生霉素不敏感肠球菌感染。
Emerg Infect Dis. 2012 Apr;18(4):674-6. doi: 10.3201/eid1804.110932.
9
Emergence of daptomycin-resistant VRE: experience of a single institution.万古霉素耐药肠球菌的出现：一家医疗机构的经验。
Infect Control Hosp Epidemiol. 2011 Apr;32(4):391-4. doi: 10.1086/659152.
10
Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.对临床医生而言，达托霉素中介粪肠球菌：一种新出现的挑战。
Clin Infect Dis. 2011 Jan 15;52(2):228-34. doi: 10.1093/cid/ciq113.

本文引用的文献

1
Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature.耐万古霉素肠球菌所致心内膜炎：病例报告及文献复习
Clin Infect Dis. 2005 Oct 15;41(8):1134-42. doi: 10.1086/444459. Epub 2005 Sep 9.
2
Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.耐万古霉素粪肠球菌感染治疗期间对达托霉素耐药的出现。
Clin Infect Dis. 2005 Aug 15;41(4):565-6. doi: 10.1086/432121.
3
Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.耐达托霉素、耐甲氧西林金黄色葡萄球菌菌血症
Clin Infect Dis. 2005 Apr 1;40(7):1058-60. doi: 10.1086/428616. Epub 2005 Feb 17.
4
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.当前用于治疗革兰氏阳性菌感染的药物疗效及耐药性后果。
Clin Microbiol Infect. 2005 May;11 Suppl 3:29-35. doi: 10.1111/j.1469-0691.2005.01139.x.
5
Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.在达托霉素治疗期间粪肠球菌中出现达托霉素耐药性。
Antimicrob Agents Chemother. 2005 Apr;49(4):1664-5. doi: 10.1128/AAC.49.4.1664-1665.2005.
6
Resistance studies with daptomycin.达托霉素的耐药性研究。
Antimicrob Agents Chemother. 2001 Jun;45(6):1799-802. doi: 10.1128/AAC.45.6.1799-1802.2001.
7
Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.145例配对的病例患者和对照患者中与耐万古霉素屎肠球菌感染或定植相关的危险因素。
Clin Infect Dis. 1996 Oct;23(4):767-72. doi: 10.1093/clinids/23.4.767.
8
Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.耐万古霉素屎肠球菌菌血症：感染的危险因素
Clin Infect Dis. 1995 May;20(5):1126-33. doi: 10.1093/clinids/20.5.1126.

De novo daptomycin nonsusceptibility in a clinical isolate.

作者信息

Lesho Emil P, Wortmann Glenn W, Craft David, Moran Kimberly A

出版信息

J Clin Microbiol. 2006 Feb;44(2):673. doi: 10.1128/JCM.44.2.673.2006.

DOI:10.1128/JCM.44.2.673.2006
PMID:16455945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1392681/
Abstract
摘要